Evaluation of an Alternative Screening Method for Gestational Diabetes Diagnosis During the COVID-19 Pandemic (DIABECOVID STUDY): An Observational Cohort Study

• DOI: 10.20944/preprints202409.1985.v1
• Publication Date: 2024-09-27T01:04:10Z
• Authors: Alba Casellas; Cristina Martinez; Judit Amigó; Roser Ferrer; Laia Marti; Carme Merced; M Carmen Medina; Istria Molinero; Marta Calveiro; Anna Maroto; Ester del Barco; Elena Carreras; Maria M. Goya
• Keywords: Pandemic; 2019-20 coronavirus outbreak

Aim: To evaluate the impact of applying alternative diagnostic criteria for gestational diabetes mellitus (GDM) during COVID-19 pandemic on GDM prevalence, obstetrical and perinatal outcomes, costs, as compared to standard method. Methods: A cohort pregnant individuals undergoing GMD screening with method, which uses plasma glucose (fasting or non-fasting) HbA1c, was a Both cohorts were obtained from 6 hospitals across Catalonia, Spain, April 2020 2022. The primary outcome large age rate at birth. Secondary outcomes composite adverse including pregnancy complications, delivery neonatal complications. Cost differences between methods also evaluated. similar analysis performed in subgroup diagnosed GDM. Results: Data collected 1,543 group 2,197 group. had higher than (10.8% vs 6.9%, respectively; p